Q1: What types of biomarkers can be detected using your biosensor platforms? A: Our platform is highly versatile and can be customized to detect a wide range of disease biomarkers, including specific proteins, nucleic acids, metabolites, and even whole cells, offering exceptional sensitivity and rapid response times.

Q2: How does your team support the development of these diagnostic tools? A: We provide comprehensive, end-to-end support ranging from the selection of biological recognition elements and electrode functionalization to signal amplification and prototype validation. By utilizing our electrochemical biosensor for disease detection services, clients can efficiently accelerate their projects from proof-of-concept to clinical application.

Q3: Are these sensors suitable for Point-of-Care Testing (POCT) integration? A: Yes. Due to their inherent miniaturization capabilities, low manufacturing costs, and ability to operate reliably in complex biological matrices (such as whole blood or saliva), they are ideal candidates for the development of rapid, user-friendly point-of-care diagnostic devices.